EichorEICHOR
Study identifier: NCT07037433 Synced from ClinicalTrials.gov · August 02, 2026
● Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Condition: Atherosclerotic Cardiovascular Disease · Overweight · Obesity  ·  Sponsor: Amgen

PhasePhase 3
Planned participants12800
Who can joinAll sexes, 45 Years to 99 Years
Healthy volunteersNo

About this study

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morbidity and mortality.

This description comes directly from the study's public registry record.

Talk to the study team

Amgen Call Center  ·  866-572-6436  ·  medinfo@amgen.com

Always discuss trial participation with your own doctor first.

Locations (782)

Alliance For Multispecialty Research - DaphneDaphne, Alabama, United StatesRecruiting
Eastern Shore Research InstituteFairhope, Alabama, United StatesRecruiting
Heart Center Research LLCHuntsville, Alabama, United StatesRecruiting
Mobile Heart Specialists PCMobile, Alabama, United StatesRecruiting
Syed Research Consultants LLCSheffield, Alabama, United StatesRecruiting
Synexus Clinical Research US, Inc.Phoenix, Arizona, United StatesRecruiting
Medical Advancement Centers of ArizonaPhoenix, Arizona, United StatesRecruiting
Valley Clinical Trials, LLC dba Flourish ResearchCovina, California, United StatesRecruiting
Velocity Clinical Research- Huntington ParkHuntington Park, California, United StatesRecruiting
Velocity Clinical Research- Los AngelesLa Mesa, California, United StatesCompleted
Orange County Research CenterLake Forest, California, United StatesRecruiting
Biopharma Informatic - The Cardiovascular CenterRedding, California, United StatesRecruiting

+ 770 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →